CDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept Dr. Divya Colin3 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved Dr Reddys...
Abatacept effectively reduces rheumatoid arthritis development in high risk patients, reveals research Jacinthlyn Sylvia7 Jan 2025 8:15 PM ISTA recent study by Maheen Asif and team unveiled great outcome of abatacept in delaying the progression of rheumatoid arthritis (RA) in high-risk...
Abatacept may decelerate progression of atherosclerosis in RA patients with CVD: Study Dr Riya Dave29 April 2024 8:30 AM ISTResearchers have found that abatacept treatment may benefit patients with rheumatoid arthritis (RA) who have a high risk of cardiovascular disease,...
Biologic drug abatacept used for treatment of RA could prevent disease as well, clinical trial shows Dr. Kamal Kant Kohli17 Feb 2024 3:30 AM ISTBiologic drug abatacept which used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk, reveals new...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Anti-inflammatory drugs may prevent death but fail to speed up recovery in COVID-19 patients Aditi27 July 2023 11:15 AM ISTAn Original Investigation published on July 10, 2023, entitled, "Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With...
Is Abatacept effective in preventing type 1 diabetes in at-risk individuals? Phase 2 trial provides insights Medha Baranwal23 March 2023 11:45 AM ISTUSA: Results from a phase 2 clinical trial indicate that abatacept use did not significantly delay the progression to abnormal glucose intolerance of...
Abatacept has better clinical response than TNFi in ACPA-positive RA patients: study Dr Supreeth D R6 Dec 2022 5:00 AM ISTPatients with rheumatoid arthritis (RA) who are anti-citrullinated protein antibody (ACPA)-positive have been shown to respond better to abatacept and...
Seropositive RA patients more often adhere to abatacept compared to TNF, JAK Inhibitors: Study Dr. Shravani Dali25 Dec 2021 9:00 AM ISTAmong seropositive RA patients, those on abatacept were more often persistent to their index treatment and had longer time to treatment...
Abatacept fails to prevent psoriasis relapse occuring after ustekinumab withdrawal: JAMA MD Editorial Team29 Oct 2021 9:00 AM ISTResearch on psoriasis pathogenesis has largely increased knowledge on skin biology in general. The mechanisms involved in the initiation and...
USFDA accepts Bristol Myers Orencia application for priority review Ruchika Sharma24 Aug 2021 12:00 PM ISTPrinceton: Bristol Myers Squibb has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted the company's...
